Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status

This study was designed to retrospectively evaluate the efficacy and safety of modified FOLFOX-6 regimen in advanced gastric cancer (AGC) patients with poor performance status (PS). From January 2005 to August 2010, 23 AGC patients with poor PS who received mFOLFOX-6 as first-line chemotherapy were...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: KIM, HYEONG SU, KIM, JUNG HAN, KIM, HEE JUN, JANG, HYUN JOO, KIM, JIN BAE, KIM, JI WON, JUNG, SO YOUNG, KIM, BYUNG CHUN, YANG, DAE HYUN, PARK, SOAH, KIM, KEONG JU, LEE, SOON IL, ZANG, DAE YOUNG
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2012
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3362383/
https://ncbi.nlm.nih.gov/pubmed/22740925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.496
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak